QQ客服 官方微博 反馈留言

	Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway
	Li, Dong; Yang, Jingyan; Ma, Huanzhi; Sun, Chengliang; Feng, Rongjie
刊名	JOURNAL OF CELLULAR BIOCHEMISTRY
	2018
卷号	119期号:12页码:9899-9909
关键词	apoptosis cell viability inositol polyphosphate-4-phosphatase osteosarcoma phosphoinositide 3-kinase/protein kinase B rucaparib type-II (inositol polyphosphate-4-phosphatase)
DOI	10.1002/jcb.27311
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4571624
专题	山东大学
作者单位	1.Shandong Univ, Shandong Prov Hosp, Dept Orthoped, Jinan, Shandong, Peoples R China. 2.Shando
推荐引用方式 GB/T 7714	Li, Dong,Yang, Jingyan,Ma, Huanzhi,et al. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway[J]. JOURNAL OF CELLULAR BIOCHEMISTRY,2018,119(12):9899-9909.
APA	Li, Dong,Yang, Jingyan,Ma, Huanzhi,Sun, Chengliang,&Feng, Rongjie.(2018).Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway.JOURNAL OF CELLULAR BIOCHEMISTRY,119(12),9899-9909.
MLA	Li, Dong,et al."Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway".JOURNAL OF CELLULAR BIOCHEMISTRY 119.12(2018):9899-9909.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。